Literature DB >> 8794328

Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.

G W Demers1, E Espling, J B Harry, B G Etscheid, D A Galloway.   

Abstract

Cells arrest in the G1 or G0 phase of the cell cycle in response to a variety of negative growth signals that induce arrest by different molecular pathways. The ability of human papillomavirus (HPV) oncogenes to bypass these signals and allow cells to progress into the S phase probably contributes to the neoplastic potential of the virus. The E7 protein of HPV-16 was able to disrupt the response of epithelial cells to three different negative growth arrest signals: quiescence imposed upon suprabasal epithelial cells, G1 arrest induced by DNA damage, and inhibition of DNA synthesis caused by treatment with transforming growth factor beta. The same set of mutated E7 proteins was able to abrogate all three growth arrest signals. Mutant proteins that failed to abrogate growth arrest signals were transformation deficient and included E7 proteins that bound retinoblastoma protein in vitro. In contrast, HPV-16 E6 was able to bypass only DNA damage-induced G1 arrest, not suprabasal quiescence or transforming growth factor beta-induced arrest. The E6 and E7 proteins from the low-risk virus HPV-6 were not able to bypass any of the growth arrest signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794328      PMCID: PMC190734     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences.

Authors:  K Münger; C L Yee; W C Phelps; J A Pietenpol; H L Moses; P M Howley
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

3.  Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16.

Authors:  J M Firzlaff; B Lüscher; R N Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression.

Authors:  J K Schwarz; C H Bassing; I Kovesdi; M B Datto; M Blazing; S George; X F Wang; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

5.  The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells.

Authors:  C L Halbert; G W Demers; D A Galloway
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.

Authors:  A Schmitt; J B Harry; B Rapp; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  p21-containing cyclin kinases exist in both active and inactive states.

Authors:  H Zhang; G J Hannon; D Beach
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

8.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

Review 9.  Cdk inhibitors: on the threshold of checkpoints and development.

Authors:  S J Elledge; J W Harper
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

10.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.

Authors:  S B Parker; G Eichele; P Zhang; A Rawls; A T Sands; A Bradley; E N Olson; J W Harper; S J Elledge
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

View more
  49 in total

1.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth.

Authors:  A Brehm; S J Nielsen; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 4.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

5.  The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.

Authors:  Benyue Zhang; Wei Chen; Ann Roman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-28       Impact factor: 11.205

6.  Immortalized keratinocyte lines derived from human embryonic stem cells.

Authors:  Shiro Iuchi; Sally Dabelsteen; Karen Easley; James G Rheinwald; Howard Green
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

7.  Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator.

Authors:  Tamaki Suganuma; Masahiro Kawabata; Tomoko Ohshima; Masa-Aki Ikeda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

8.  Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.

Authors:  Anna-Marija Helt; Jens Oliver Funk; Denise A Galloway
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.

Authors:  Wanxia He; Doug Staples; Clark Smith; Chris Fisher
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.